A share price of Biosig Technologies Inc [BSGM] is currently trading at $0.66, down -9.45%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The BSGM shares have gain 24.72% over the last week, with a monthly amount drifted -11.87%, and not seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
On 20, February 2024, BioSig Announces Reduction of its Workforce. In a post published today on Yahoo Finance, — BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company, today announced that it has terminated a significant number of its employees and expects to substantially reduce business operations.
From an analyst’s perspective:
Biosig Technologies Inc [NASDAQ: BSGM] stock has seen the most recent analyst activity on March 30, 2020, when ROTH Capital initiated its Buy rating and assigned the stock a price target of $9.
Biosig Technologies Inc experienced fluctuations in its stock price throughout the past year between $0.26 and $16.50. Biosig Technologies Inc [NASDAQ: BSGM] shares were valued at $0.66 at the most recent close of the market.
Analyzing the BSGM fundamentals
Trailing Twelve Months sales for Biosig Technologies Inc [NASDAQ:BSGM] were 0.14M which represents -99.26% decline. Gross Profit Margin for this corporation currently stands at -2.11% with Operating Profit Margin at -208.11%, Pretax Profit Margin comes in at -209.63%, and Net Profit Margin reading is -212.76%. To continue investigating profitability, this company’s Return on Assets is posted at -9.51, Equity is -67.0 and Total Capital is 38.76. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at -0.5.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 0.6167 points at the first support level, and at 0.5733 for the second support level. However, for the 1st resistance point, the stock is sitting at 0.7367, and for the 2nd resistance point, it is at 0.8133.
Biosig Technologies Inc [BSGM] reported earnings per share of -$0.6 for its fiscal quarter that ended on 9/29/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$1/share, meaning a difference of $0.4 and a surprise factor of 40.00%. By comparison, the stated earnings for the previous quarter ended on 6/29/2023 were -$1.6 per share as compared to estimates of -$0.97 per share, a difference of -$0.63 representing a surprise of -64.90%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Biosig Technologies Inc [NASDAQ:BSGM] is 0.27. As well, the Quick Ratio is 0.21, while the Cash Ratio is 0.1. Considering the valuation of this stock, the price to sales ratio is 44.05.
Transactions by insiders
Recent insider trading involved LONDONER KENNETH L, Chief Executive Officer, that happened on Jun 13 ’23 when 15600.0 shares were purchased. Chief Executive Officer, LONDONER KENNETH L completed a deal on Jun 12 ’23 to buy 6000.0 shares. Meanwhile, Chief Executive Officer LONDONER KENNETH L bought 4600.0 shares on Jun 02 ’23.
